<p>➀ MIT engineers developed an implantable device that wirelessly delivers emergency drugs like glucagon (for hypoglycemia) and epinephrine (for allergic reactions); </p><p>➀ The nickel-titanium alloy sealed device uses radiofrequency signals to trigger drug release when needed, integrating with glucose monitors for automated diabetes management; </p><p>➂ Successful animal trials showed rapid blood sugar stabilization, with plans for extended durability testing and human clinical trials within 3 years</p>